EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries

Toon Wei Lim, Alan John Camm, Saverio Virdone, Daniel E Singer, Jean P Bassand, Gregg C Fonarow, Keith A A Fox, Michael Ezekowitz, Bernard J Gersh, Gloria Kayani, Elaine M Hylek, Ajay K Kakkar und 5 weitere

Clinical Cardiology · 2023-11 · 46 (11) · 1398-1407

DOI: 10.1002/clc.24109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 18.08.2023. Verfasst von Toon Wei Lim und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Heart Centre, Singapore, Singapore. Hauptthemen laut MEDLINE: Atrial Fibrillation, Stroke, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thrombosis Research Institute, Janssen Scientific Affairs LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An unmet need exists to reliably predict the risk of intracranial hemorrhage (ICH) in patients with atrial fibrillation (AF) treated with oral anticoagulants (OACs). Hypothesis An externally validated model improves ICH risk stratification.

Methods

Independent factors associated with ICH were identified by Cox proportional hazard modeling, using pooled data from the GARFIELD‐AF (Global Anticoagulant Registry in the FIELD‐Atrial Fibrillation) and ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) registries. A predictive model was developed and validated by bootstrap sampling and by independent data from the Danish National Patient Register.

Results

In the combined training data set, 284 of 53 878 anticoagulated patients had ICH over a 2‐year period (0.31 per 100 person‐years; 95% confidence interval [CI]: 0.28–0.35). Independent predictors of ICH included: older age, prior stroke or transient ischemic attack, concomitant antiplatelet (AP) use, and moderate‐to‐severe chronic kidney disease (CKD). Vitamin K antagonists (VKAs) were associated with a significantly higher risk of ICH compared with non‐VKA oral anticoagulants (NOACs) (adjusted hazard ratio: 1.61; 95% CI: 1.25–2.08; p = .0002). The ability of the model to discriminate individuals in the training set with and without ICH was fair (optimism‐corrected C ‐statistic: 0.68; 95% CI: 0.65–0.71) and outperformed three previously published methods. Calibration between predicted and observed ICH probabilities was good in both training and validation data sets.

Conclusions

Age, prior ischemic events, concomitant AP therapy, and CKD were important risk factors for ICH in anticoagulated AF patients. Moreover, ICH was more frequent in patients receiving VKA compared to NOAC. The new validated model is a step toward mitigating this potentially lethal complication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationStrokeRenal Insufficiency, ChronicHumansAnticoagulantsAdministration, OralIntracranial HemorrhagesRisk FactorsRegistriesVitamin K

Stichwörter der Autor:innen

anticoagulationatrial fibrillation (AF)chronic kidney diseaseintracranial hemorrhage (ICH)nonvitamin K antagonist (NOAC)oral anticoagulant (OAC)real-world evidence (RWE)risk predictionvitamin K antagonist (VKA)

Substanzen

AnticoagulantsVitamin K

Autor:innen und Institutionen

  • National Heart Centre, Singapore, Singapore.
  • National University Hospital, Singapore, Singapore.
  • Cardiology Clinical Academic Group Molecular & Clinical Sciences Institute, St. George's University of London, London, UK.
  • Thrombosis Research Institute, London, UK.
  • Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Cardiology, University of Besançon, Besançon, France.

Förderung

  • Thrombosis Research Institute
  • Janssen Scientific Affairs LLC

Zitieren

APA

Lim, T. W., Camm, A. J., Virdone, S., Singer, D. E., Bassand, J. P., Fonarow, G. C., Fox, K. A. A., Ezekowitz, M., Gersh, B. J., Kayani, G., Hylek, E. M., Kakkar, A. K., Mahaffey, K. W., Pieper, K. S., Peterson, E. D., Piccini, J. P., & GARFIELD-AF and ORBIT-AF Investigators (2023). Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries. Clinical Cardiology, 46(11), 1398-1407. https://doi.org/10.1002/clc.24109

Vancouver

Lim TW, Camm AJ, Virdone S, Singer DE, Bassand JP, Fonarow GC, et al. Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries. Clinical Cardiology. 2023;46(11):1398-1407. doi:10.1002/clc.24109

BibTeX
@article{Lim2023,
  author = {Lim, Toon Wei and Camm, Alan John and Virdone, Saverio and Singer, Daniel E and Bassand, Jean P and Fonarow, Gregg C and Fox, Keith A A and Ezekowitz, Michael and Gersh, Bernard J and Kayani, Gloria and Hylek, Elaine M and Kakkar, Ajay K and Mahaffey, Kenneth W and Pieper, Karen S and Peterson, Eric D and Piccini, Jonathan P and GARFIELD-AF and ORBIT-AF Investigators, GARFIELD-AF and ORBIT-AF Investigators},
  title = {Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries},
  journal = {Clinical Cardiology},
  year = {2023},
  volume = {46},
  number = {11},
  pages = {1398--1407},
  doi = {10.1002/clc.24109}
}
Kostenlos starten →